Log in
Enquire now

List of Biolex Therapeutics patents

List of Biolex Therapeutics patents
List of ADENOSINE THERAPEUTICS, LLC patents
List of Angion Biomedica Corp. patents
List of Nei (footballer, born 1985) patents
List of awards received by Hal Holbrook
List of funding rounds for ProducePay
Patents where
Current Assignee
Name
is
Biolex TherapeuticsBiolex Therapeutics
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 7884264 Compositions and methods for inhibition of fucosyltransferase and xylosyltransferase expression in duckweed plants

Patent 7884264 was granted and assigned to Biolex Therapeutics on February, 2011 by the United States Patent and Trademark Office.

Biolex Therapeutics
Biolex Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
7884264
February 8, 2011
‌
US Patent 7326385 Plate and method for high throughput screening

Patent 7326385 was granted and assigned to Biolex Therapeutics on February, 2008 by the United States Patent and Trademark Office.

Biolex Therapeutics
Biolex Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
7326385
February 5, 2008
‌
US Patent 7632983 Expression of monoclonal antibodies in duckweed

Patent 7632983 was granted and assigned to Biolex Therapeutics on December, 2009 by the United States Patent and Trademark Office.

Biolex Therapeutics
Biolex Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
7632983
December 15, 2009
‌
US Patent 7709699 Use of duckweed in high throughput screening

Patent 7709699 was granted and assigned to Biolex Therapeutics on May, 2010 by the United States Patent and Trademark Office.

Biolex Therapeutics
Biolex Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
7709699
May 4, 2010
‌
US Patent 7659445 Expression of plasminogen and microplasminogen in duck weed

Patent 7659445 was granted and assigned to Biolex Therapeutics on February, 2010 by the United States Patent and Trademark Office.

Biolex Therapeutics
Biolex Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
7659445
February 9, 2010
‌
US Patent 7736674 Controlled release compositions for interferon based on PEGT/PBT block copolymers

Patent 7736674 was granted and assigned to Biolex Therapeutics on June, 2010 by the United States Patent and Trademark Office.

Biolex Therapeutics
Biolex Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
7736674
June 15, 2010
‌
US Patent 8137661 Controlled release interferon drug products and treatment of HCV infections using same

Patent 8137661 was granted and assigned to Biolex Therapeutics on March, 2012 by the United States Patent and Trademark Office.

Biolex Therapeutics
Biolex Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
8137661
March 20, 2012
‌
US Patent 8034916 Expression control elements from the

Patent 8034916 was granted and assigned to Biolex Therapeutics on October, 2011 by the United States Patent and Trademark Office.

Biolex Therapeutics
Biolex Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
8034916
October 11, 2011
‌
US Patent 8022270 Expression of biologically active polypeptides in duckweed

Patent 8022270 was granted and assigned to Biolex Therapeutics on September, 2011 by the United States Patent and Trademark Office.

Biolex Therapeutics
Biolex Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
8022270
September 20, 2011
‌
US Patent 8182803 C-terminally truncated interferon alpha variants

Patent 8182803 was granted and assigned to Biolex Therapeutics on May, 2012 by the United States Patent and Trademark Office.

Biolex Therapeutics
Biolex Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
8182803
May 22, 2012
‌
US Patent 7915483 C-terminally truncated interferon

Patent 7915483 was granted and assigned to Biolex Therapeutics on March, 2011 by the United States Patent and Trademark Office.

Biolex Therapeutics
Biolex Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
7915483
March 29, 2011
‌
US Patent 7867518 Controlled release compositions for interferon based on PEGT/PBT block copolymers and method for preparation thereof

Patent 7867518 was granted and assigned to Biolex Therapeutics on January, 2011 by the United States Patent and Trademark Office.

Biolex Therapeutics
Biolex Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
7867518
January 11, 2011
‌
US Patent 8017836 Expression of plasminogen and microplasminogen in duckweed

Patent 8017836 was granted and assigned to Biolex Therapeutics on September, 2011 by the United States Patent and Trademark Office.

Biolex Therapeutics
Biolex Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
8017836
September 13, 2011
‌
US Patent 7959910 C-terminally truncated interferon alpha variants

Patent 7959910 was granted and assigned to Biolex Therapeutics on June, 2011 by the United States Patent and Trademark Office.

Biolex Therapeutics
Biolex Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
7959910
June 14, 2011
‌
US Patent 8163307 Controlled release compositions for interferon based PEGT/PBT block copolymers and method for preparation thereof

Patent 8163307 was granted and assigned to Biolex Therapeutics on April, 2012 by the United States Patent and Trademark Office.

Biolex Therapeutics
Biolex Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
8163307
April 24, 2012
15 results
0 selected
15 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us